Literature DB >> 785600

Botulinum toxin: mechanism of presynaptic blockade.

I Kao, D B Drachman, D L Price.   

Abstract

The mechanism of action of botulinum toxin was analyzed by the use of calcium ionophores and black widow spider venom. Addition of calcium ionophores to nerve-muscle preparations blocked by botulinum toxin did not increase the frequency of miniature end plate potentials. However, the spider venom elicited a barrage of miniature end plate potentials after blockade by botulinum. Electron micrographs of preparations treated with botulinum toxin and then the spider venom revealed clumping of synaptic vesicles at release sites in the otherwise depleted nerve terminals. These findings indicate that the action of botulinum toxin is not due to deficient storage of acetylcholine in vesicles or blockade of calcium entry into nerve terminals. They suggest that the toxin interferes with the acetylcholine release process itself, possibly by blocking exocytosis at the release sites.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 785600     DOI: 10.1126/science.785600

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  51 in total

1.  Intrinsic properties of the adult human mylohyoid muscle: neural organization, fiber-type distribution, and myosin heavy chain expression.

Authors:  Min Ren; Liancai Mu
Journal:  Dysphagia       Date:  2005       Impact factor: 3.438

2.  Single intracerebroventricular injection of botulinum toxin type A produces slow onset and long-term memory impairment in rats.

Authors:  Zdravko Lacković; Veseljka Rebić; Peter F Riederer
Journal:  J Neural Transm (Vienna)       Date:  2009-08-20       Impact factor: 3.575

3.  Action of brown widow spider venom and botulinum toxin on the frog neuromuscular junction examined with the freeze-fracture technique.

Authors:  D W Pumplin; T S Reese
Journal:  J Physiol       Date:  1977-12       Impact factor: 5.182

4.  Effect of treatment with botulinum toxin on spasticity.

Authors:  T K Das; D M Park
Journal:  Postgrad Med J       Date:  1989-04       Impact factor: 2.401

5.  Effect of botulinum toxin on extraocular muscle proprioception.

Authors:  E Manni; B Bagolini; V E Pettorossi; P Errico
Journal:  Doc Ophthalmol       Date:  1989-06       Impact factor: 2.379

6.  Zinc antagonizes the effect of botulinum type A toxin at the mouse neuromuscular junction.

Authors:  M Nishimura; S Kozaki; G Sakaguchi
Journal:  Experientia       Date:  1988-01-15

Review 7.  Clinical uses of botulinum toxin A in smile aesthetic modification.

Authors:  S N Delpachitra; A W Sklavos; M Dastaran
Journal:  Br Dent J       Date:  2018-09-28       Impact factor: 1.626

8.  A comparison of miniature end-plate potentials at normal, denervated, and long-term botulinum toxin type A poisoned frog neuromuscular junctions.

Authors:  M T Lupa; S P Yu
Journal:  Pflugers Arch       Date:  1986-11       Impact factor: 3.657

9.  A comparison of bilateral and unilateral botulinum toxin treatments for spasmodic dysphonia.

Authors:  P Zwirner; T Murry; G E Woodson
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

10.  Efficacy and safety of serial injections of botulinum toxin A in children with spastic cerebral palsy.

Authors:  Ya-Jie Wang; Bao-Qin Gao
Journal:  World J Pediatr       Date:  2013-11-14       Impact factor: 2.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.